Abstract Neuronal accumulation of oligomeric amyloid-( ) is considered the proximal cause of neuronal demise in Alzheimer disease (AD) patients. Blood-borne macrophages might reduce A stress to neurons by immigration into the brain and phagocytosis of . We tested migration and export across a blood-brain barrier model, and phagocytosis and clearance of by AD and normal subjects' macrophages. Both AD and normal macrophages were inhibited in export across the blood-brain barrier due to adherence of A -engorged macrophages to the endothelial layer. In comparison to normal subjects' macrophages, AD macrophages ingested and cleared less , and underwent apoptosis upon exposure to soluble, protoWbrillar, or Wbrillar . Confocal microscopy of stained AD brain sections revealed oligomeric A in neurons and apoptotic macrophages, which surrounded and inWltrated congophilic microvessels, and Wbrillar A in plaques and microvessel walls. After incubation with AD brain sections, normal subjects' monocytes intruded into neurons and uploaded oligomeric A . In conclusion, in patients with AD, macrophages appear to shuttle A from neurons to vessels where their apoptosis may release Wbrillar A , contributing to cerebral amyloid angiopathy.
. A is potentially generated from A precursor protein (APP) wherever APP and the -and -secretases are located, such as the endoplasmic reticulum and Golgi apparatus, but most is produced at the plasma surface or in the secretory pathway [25] . A generation may also occur during autophagic turnover of APP-rich organelles [32] . Increasing molecular weight assemblies of A accumulate both extra-and intra-neuronally in Alzheimer disease (AD) brain [25] ; of these assemblies, at least the intraneuronal oligomeric A has pathological consequences [43] . A is cleared physiologically across the blood-brain barrier by low-density lipoprotein receptor-related protein-1 [35] . Despite this physiological clearance, A is found to accumulate in neurons and extracellular deposits since the Wrst year of life. The pathological consequences in AD patients are intraneuronal accumulation of oligomeric A in multivesicular bodies [18] and neuronal death. Surprisingly, the total neuronal load of A is not predictive of neuroWbrillary degeneration [47] .
Brain amyloidosis of AD patients is considered to be related to insuYcient clearance rather than over-expression of A [42] . Promising strategies for immune clearance of A include A vaccination [48] , intravenous gamma-globulin [39] , humanized anti-A antibody (Bapineuzumab ® ), and transcriptional modulation of macrophages, such as by use of curcuminoids [15] . Studies of AD brain tissues [11] and, recently, of APP transgenic mice brain tissues [28, 30, 37] suggest that blood-derived macrophages and microglia, rather than resident brain microglia, have a key role in the clearance of A .
Previous studies have identiWed basic immune mechanisms necessary for clearance of A by macrophages. Ainduced adhesion molecules and chemokines CCL3 (MIP-1 ), CCL4 (MIP-1 ), and CCL2 [9, 17, 38] act on macrophages, microglia, and astrocytes, promoting monocyte migration, diVerentiation [9] , and survival [19] . In mouse macrophages and microglia, the class B scavenger receptor type 2 (CD36) is crucial for induction by A of chemokines, cytokines, and reactive oxygen species [6, 34] , and exposure to A initiates the signaling cascade that links CD36 scavenger receptor to the actin cytoskeleton and diverse processes such as cellular migration, adhesion, and phagocytosis [41] . Fucoidan inhibits both class A and B scavenger receptor interactions [21] , but, in our experience, does not inhibit A phagocytosis by human macrophages (Fiala et al. unpublished data) . Recent studies suggest a role for Toll-like receptors (TLR's) in A clearance: TLR's are transcriptionally downregulated in AD patients' monocytes [15] , and TLR-2 signaling enhances A uptake by microglia [4] . Importantly, mononuclear cells of most patients diVer from those of normal subjects by transcriptional downregulation of -1,4-mannosyl-glycoprotein 4--N-acetylglucosaminyltransferase (MGAT-3), an enzyme important in phagocytosis of A [15] .
Immunohistochemical studies brought new insights into the immune clearance of A by macrophages in human brain. AD brain contains 11 times as many cyclooxygenase (COX-2)-positive macrophages as age-matched control brain [11] , and a subset of these macrophages is inducible nitric oxide (NO) synthase (iNOS)-positive [10] . Monocyte immigration might be orchestrated by neuronal and microglial chemokine RANTES and cytokine interleukin-1 (IL-1 ) [13, 31] . In CCR2-deWcient APP transgenic mice, clearance of A is depressed [7] . Despite the permeation of AD brain by macrophages, clearance of neuritic plaques is randomly incomplete, suggesting functional heterogeneity of AD macrophages [13] .
AD is a human disease with speciWc immune and biochemical defects [15] , which have not been engineered in APP transgenic mice. To clarify the pathophysiology of A clearance in AD, we examined A clearance using human brain tissues and human macrophages, and observed that the AD innate immune system is defective in proper disposal of A in the brain.
Materials and methods

Antibodies and reagents
We stained macrophages using mouse anti-human CD68 (Dako, Carpinteria, CA) and goat anti-human CD68 (Santa Cruz Biotech, Santa Cruz, CA, USA). Neurons were stained with mouse anti-human neuronal nuclei (NeuN, Chemicon, Temecula, CA, USA); mouse anti-human microtubule associated protein 2 (MAP2, Sigma, St Louis, MO, USA); and rabbit anti-human neuron speciWc enolase (Immunostar, Hudson, WI, USA). To visualize A in brain tissue and in macrophages, we utilized rabbit anti-A 1-42 (COOH-terminal epitope) (Millipore, Billerica, MA, USA); mouse biotinylated anti-A 1-42 (COOH-terminal epitope) (Signet); rabbit anti-oligomer A11 (Biosource, Carlsbad, CA, USA), which recognizes A -42 and A -40 pre-Wbrillar oligomers [22] ; and rabbit anti-Wbrillar OC, which stains A Wbrils, as well as -synuclein Wbrils and islet amyloid polypeptide Wbrils [23] . To stain apoptotic markers, we used anti-caspase-6, -7, and -8 antibodies, which were raised in rabbits using catalytic subunits of the relevant autoprocessed recombinant caspases as immunogens (Burnham Institute, La Jolla, CA, USA) [24] . Secondary antibodies were anti-mouse, anti-rabbit, and anti-goat IgG's conjugated to Alexa Fluor 488, 555, and 647 (Invitrogen, Carlsbad, CA, USA). The reagents were monocyte chemotactic protein-1 (MCP-1) (PeproTech, Rocky Hill, NJ, USA); Xuorescein isothiocyanate (FITC)-conjugated A (Anaspec, San Jose, CA, USA); Wbrillar FITC-A and protoWbrillar A prepared by M. Inayathullah; and 14 C-labeled A from C. Glabe, UCI. A was used at 2 g/mL in most experiments. [29] were recruited into the study since 2004 through the University of California, Los Angeles (UCLA), Alzheimer's Disease Research Center under a UCLA Institutional Review Board-approved protocol. In addition, eight aged-matched control subjects (mean age 77.5 + 6.0 years) and three young control subjects (ages 20, 21, 44) were recruited from UCLA personnel and families of patients.
Patients and controls
Isolation of PBMC's
Peripheral blood mononuclear cells (PBMC's) were isolated from venous blood of the AD patients and control subjects by Ficoll-Hypaque gradient centrifugation as previously described [13] . Monocytes were puriWed using RosetteSep Monocyte Enrichment Cocktail (StemCell Technologies, Vancouver, BC, Canada) from PBMC's of normal subjects ("normal monocytes" or "normal macrophages") and AD patients ("AD monocytes" or AD macrophages").
Preparation of Wbrils and protoWbrils of A (1-42)
A Wbrils were prepared by dissolving 1 mg of A peptide in 100 L of 10 mM NaOH. The solution was diluted to a volume of 0.5 mL with milliQ water followed by addition of 0.5 mL of 10 mM (2£) phosphate buVer (pH 7.4). The resulting solution was then centrifuged at 16,000£g for 10 min. One-half milliliter of the resulting supernatant was transferred into a new tube and incubated at 37°C for 7 days. The Wbrils were pelleted out by centrifugation for 10 min and the supernatant was transferred to another tube for protoWbril isolation. The Wbril pellet was washed thrice with MilliQ water and the resulting pellet thereafter resuspended in MilliQ water after each wash.
ProtoWbrils were isolated from the supernatant by Wltering through a Centricon Wlter (molecular weight cutoV of 35 kDa) to remove any small oligomers and monomers and collecting the Wltrate. The pellet was washed three times with MilliQ and then reconstituted and diluted with MilliQ water. A small aliquot of each sample was analyzed by amino acid analysis to determine the protein concentration. The samples were characterized by size exclusion chromatography and electron microscopy (Fig. 2) . Fibrillar and protoWbrillar A also was prepared in smaller amounts from FITC-A .
Monocyte migration across a human blood-brain barrier model
A human blood-brain barrier model (BBB) model with primary human brain microvascular endothelial cells (BMVEC's) was constructed in a 24-well plate as described previously [8, 12] . In the model, 50,000 BMVEC's in passages 4-8 coated either the upper surface ("regular model") or the lower surface of a porous membrane insert (Collaborative Biomedical Products, Bedford, MA, USA) ("reverse model") which rests above a well. Both the well and the membrane insert contained RPMI medium with 10% fetal bovine serum or 10% autologous serum.
In migration experiments, 250,000 monocytes from two control subjects (ages 74 and 78) and two AD patients (ages 80 and 84 with MMSE scores 20 and 23, respectively) were allowed to migrate across the BBB for 17 h. The number of transmigrated cells was determined by triplicate cell counting in eight sections of a hemocytometer chamber. The inserts were washed gently with a buVer containing 0.1 M sodium cacodylate plus 0.2 M sucrose X2, then Wxed with 3% glutaraldehyde in 0.1 M sodium cacodylate buVer for 1 h at 25°C [26] . The cells were stored in this buVer at 4°C, post-Wxed with 1% osmium tetroxide at 4°C, dehydrated in an ethanol series and embedded in plastic [27] . One-micron sections were stained with toluidine blue and examined by bright Weld and transmission electron microscopy.
A phagocytosis and apoptosis by macrophages
Macrophages of four controls (ages 74, 74, 81, 90) and four AD patients (ages 70, 77, 82, 86 with MMSE scores 15, 27, 19, 27, respectively) were prepared in 8-well chamber slides as described [13] . The cultures were incubated with Wbrillar or protoWbrillar A for 3 days. Macrophage apoptosis was determined using the FLICA VAD-FMK polycaspases assay kit (Immunohistochemistry Technologies, Bloomington, MN, USA). This assay utilizes a membrane permeant, sulforhodamine B (SR)-labeled inhibitor targeted to all active caspases to covalently label apoptotic cells. Macrophage cultures were incubated with the FLICA apoptosis detection probe for 1 h at 37°C and then washed to remove any non-covalently bound probe from non-apoptotic cells. Cells were examined with an Olympus Bmax Xuorescence microscope with 100£ objective. Fluorescence density was determined by Image-Pro Plus 4.1 (Media Cybernetics, Silver Spring, MD). We examined the middle strip of each well for 6-9 consecutive Welds with macrophages, analyzing the integrated optical density (IOD) of A (green) and FLICA (red) per macrophage in three experiments for each group.
In a set of related experiments, control and AD macrophages were incubated with soluble FITC-A for 1 h, or 3, 5, or 7, and apoptosis was detected using the FLICA assay. In some experiments, macrophages were incubated with soluble unconjugated A for 1 h, washed twice, then incubated for 2, 4, or 6 days. Apoptosis was determined by the FLICA assay, and A Wbrils and oligomers were detected by the indirect technique using OC and A11 antibodies, respectively.
ELISA assay of A clearance from monocytes
PuriWed monocytes (300,000 per sample) were incubated with soluble A (2 g/mL) for 2 h, washed four times, reincubated for the indicated number of days, and the amount of intracellular A remaining at each time point was determined (0, 1, 2, 3, 5, and 7 days). To measure the amount of intracellular A , the cells were harvested into an ELISA lysis buVer (Invitrogen), supplemented with a protease inhibitor cocktail (Sigma) and assayed using the A 1-42 ELISA kit (Invitrogen) by spectrophotometry. Monocytes from four control subjects and three AD patients were tested.
Brain tissues
Frozen sections from the frontal lobe of two control subjects with no neuropathology (ages 23 and 37) and four AD patients were provided by the UCLA Brain Bank. The AD brain sections were from: (1) a 62-year-old patient with Binswanger encephalopathy and scattered senile plaques in the entorhinal cortex and hippocampus; (2) a 64-year-old Braak stage VI patient; (3) a 69-year-old Braak stage VI patient; (4) an 82-year-old Braak stage VI patient with Lewy body disease.
Co-incubation of PBMC's with brain tissues
Frozen sections of post-mortem brain tissues of four AD patients and two controls were co-incubated with 500,000 PBMC's (from seven normal donors, ages 20, 21, 72, 74, 74, 79, and 85 years old) for 1 to 6 days in Dulbecco's Minimum Essential Medium (DMEM) with 10% fetal calf serum, washed with PBS, Wxed with 4% paraformaldehyde, and processed for immunoXuorescence.
In some experiments, PBMC's were Wrst pre-labeled with Qtracker 525, which distributes green Qdot nanocrystals in cytoplasmic vesicles, or CellTracker CMFDA (Invitrogen, Carlsbad, CA, USA), which undergoes an esterase reaction to produce a green Xuorescent product in the cytoplasm. After isolation of PBMC's from blood, cells were incubated with Qtracker or CellTracker according to the manufacturer's recommendations, pelleted and washed twice with DMEM, and then incubated with tissues as above.
ImmunoXuorescence and confocal microscopy of brain tissues Fixed tissues were permeabilized with 1% Triton X-100 and blocked with 1% bovine serum albumin (BSA) at 37°C for 30 min each. Brain sections were then incubated with various primary antibodies for 48 h at 4°C, washed with PBS, and incubated with appropriate secondary antibodies labeled with Alexa 488, Alexa 555, and Alexa 647 Xuorophores for 1 h at 37°C. A mixture consisting of 0.2% Triton X-100 and 1% BSA was used as the diluent of both primary and secondary antibodies. As control staining, the sections were stained by secondary antibodies without primary antibodies. The preparations were examined using a Zeiss 510 Meta multiphoton confocal microscope or a Bio-Rad Laboratories MRC-1024 Es laser scanning confocal system attached to a Nikon E800 Xuorescent microscope.
Statistical analysis
The data on monocyte migration and 14 Ctransport were analyzed by t test and Mann-Whitney and Kruskall-Wallis tests.
Results
A uptake by monocytes inhibits monocyte emigration and A export across BBB
In the human BBB model, we compared the rate of migration by normal monocytes in both directions using either a regular model (blood chamber above apical side of BMVEC's) or a reverse model (brain chamber above abluminal side of BMVEC's). The rate was greater in the direction from brain to blood (36.4 § 0.7%) compared to that from blood to brain (13.6 § 2%). In the course of inXammation, chemokines stimulate and lipoxins inhibit leukocyte migration; to conWrm the value of this model in replicating in vivo mononuclear cell migration, we used either the chemokine MCP-1 (CCL2) alone or both MCP-1 and lipoxin A 4 together in the lower chamber. MCP-1 (50 ng/mL) increased monocyte migration from 0.4 § 0.8% to 6.5 § 0.2%, and lipoxin A 4 decreased this migration in a dose-responsive fashion from 6.5% with MCP-1 alone to 3.1 § 0.1% [0.1 nM (lipoxin A 4 , plus 50 ng/mL MCP-1)], 1.6 § 0.1% (1 nM), and 0.8 § 0.1% (10 nM). We then investigated A export using the reverse model with the chemokine MCP-1 in the lower chamber. As expected, the emigration of monocytes was highest (77,250 § 9,032) in the presence of MCP-1 in the lower chamber and lowest without MCP-1 (5,375 § 411). When 14 C-A (10,000 DPM or 1 g/mL) was placed in the brain chamber, monocyte emigration was reduced by 62% (from 77,250 § 9,032 to 29,600 § 8,988) (Table 1) . Furthermore, maximal 14 C-A export across the blood brain barrier was found in the absence of monocytes (mean § SEM, 1,960 § 198 CPM). The presence of monocytes in the upper chamber diminished export by 13% (to 1,712 § 94 CPM), and monocytes in the upper chamber with MCP-1 in the lower chamber reduced the export by 26% (1,456 § 168 CPM, P < 0.05) ( Table 1 ). In two subsequent experiments with two diVerent control/AD subject pairs, both AD and normal monocytes were inhibited in migration by A -loading (SI Fig. 1 ).
To visualize monocyte migration, the BBB models from the wells with A [either Wbrillar (Fig. 1a) or soluble (Fig. 1b) ] or without A (Fig. 1c, d) were Wxed, sectioned, stained using toluidine blue, and examined by light and transmission electron microscopy. Large macrophages with vacuoles suggestive of uploaded A were adherent to thin endothelial cells (Fig. 1a, b) . In the wells without A , monocytes freely migrated across the BBB model and, the endothelial cells displayed tall cytoplasm and abundant mitochondria (Fig. 1c, d ). Thus macrophages loaded with A adhere to endothelial cells and are inhibited in emigration across the BBB.
Normal monocytes bind and clear more A in comparison to AD monocytes When tested in bulk by A ELISA, normal monocytes uploaded more A and cleared it more rapidly than AD monocytes (Fig. 2) . After the initial 2 h incubation, control monocytes bound an average of 256 pg/mL A , compared to 112 pg/mL by AD monocytes. After thorough washing and re-incubation for 24 h, control monocytes had cleared on average 54% of the uploaded A while AD monocytes had degraded only 28%. Monocytes, which were exposed to A (2 g/mL) [Wbrillar (a) and soluble (b)] in the upper chamber and attracted for migration by MCP-1 (50 ng/mL) in the lower chamber, adhered to brain endothelial cells, which appeared Xat. Monocytes, which were not exposed to A , migrated freely across endothelial cells (c) (light microscopy, £100) and the endothelial cells exposed to migrating monocytes became tall and disorganized with a monocyte migrating to the abluminal side (d) (transmission electron microscopy, £22,000) Fibrillar, protoWbrillar, and soluble A induce apoptosis of AD macrophages After 3-day exposure to Wbrillar A (Fig. 3a) , AD macrophages displayed large Wbrils and showed a robust apoptotic signal, whereas in normal macrophages A was found in small fragments and the macrophages showed a low apoptotic signal (Fig. 4a) . Similarly, after 3-day exposure to protoWbrillar A (Fig. 3b) , AD macrophages displayed a robust apoptotic signal, whereas normal macrophages had almost no apoptotic signal although they showed a high uptake of protoWbrils (Fig. 4b) . After only 1-h exposure to soluble FITC-A , an apoptotic FLICA signal became visible in AD, but not control, macrophages; by 5 days AD macrophages were seen to be disrupted (Fig. 5a) . In a follow-up experiment AD macrophages which were incubated with soluble A for 1 h, washed, and re-incubated for 4 or 6 days demonstrated a strong apoptotic signal and lysed and heterogeneously contained and released oligomeric and Wbrillar A (Fig. 5b) . In comparison, control macrophages showed a weak FLICA signal, intracellular A decreased and the cells remained intact.
explore macrophage clearance of A from AD brain, we Wrst examined the distribution of A assemblies in AD brain sections.
Soluble and oligomeric A are present in neurons and macrophages, and Wbrillar A in plaques and congophilic microvessels In AD brain tissues, A was detected in neurons in a patchy but distinct fashion using immunoXuorescence with anti-A 1-42 (COOH terminal) (Fig. 6a) or anti-oligomer antibodies (Fig. 6b) . Fibrillar A was detected in neuritic plaques and brain vessels using the OC antibody; CD68-positive cells inWltrated plaques and vessels (Fig. 6c) . Clusters of macrophages, which were loaded with oligomeric A (Fig. 6d) , abutted and inWltrated the wall of brain vessels and displayed activated caspases: initiator caspase-6, and eVector caspases -7 and -8, indicating their apoptosis (Fig. 6e, f, g ). The brain vessels displayed Wbrillar (Fig. 6c) but not oligomeric A (Fig. 6d) . Unstained AD tissues, as well as tissues incubated with secondary but not primary antibodies, were inspected by Xuorescence microscopy and their weak Xuorescent signal due to autoXuorescence was easily distinguished from the speciWc signal in preparations stained with both primary and secondary antibodies. In addition, control brain tissues did not disclose many inWltrating macrophages.
Monocytes upload soluble and oligomeric A in neurons
To experimentally investigate the brain clearance of A , we co-incubated AD brain sections with control PBMC's for 3 days. Examination of these tissues by confocal microscopy showed monocytes (green) colocalizing in a patchy fashion with neurons (red) and uploading oligomeric (blue). The soma of the monocytes was found in higher z-sections compared to the soma of the neurons suggesting intrusion of these monocytes into neurons from above. In midsections, neurons, monocytes, and A all colocalized (Fig. 7a) . In addition, after 24 h incubation with AD brain sections, CellTracker and Qtracker prelabeled monocytes were seen to co-localize with neurons, conWrming intrusion of exogenous monocytes into neurons (Fig. 6b) . We did not notice obvious diVerences in clearance of A between the monocytes of younger and elderly control subjects but did not analyze these diVerences. We also stained AD brain tissues co-incubated without exogenous monocytes but did not Wnd CD68 positive monocytes intruding into neurons. 
Discussion
In transgenic animal models of AD, A -induced pathology seems to be upstream of tau and is considered the primary mechanism [33] . We have attempted to glean the mechanisms responsible for clearance of A from human brain by comparing the results of morphologic and experimental investigations. Although emigration of macrophages across the BBB has been infrequently investigated, macrophage immigration is well known in HIV-1 encephalitis and is becoming accepted in AD [11] . Our results in the model BBB exclude the emigration of A -engorged macrophages as a mechanism of A clearance since these adhered to the endothelium and were inhibited in emigration. Thus the fate of A in aging brain seems to depend upon its handling and degradation inside the BBB.
Our observations suggest that oligomeric A in perivascular macrophages may contribute to the Wbrillar A in congophilic vessels. AD macrophages are defective in uptake of A (Fig. 3 ), yet are particularly susceptible to apoptosis from all assembly states of A (Figs. 4, 5) , contrasting with the ability of control macrophages to phagocytize A [15] and to resist apoptosis (Figs. 4, 5) . The phagocytic propensity of AD macrophages is compounded by their low clearance of A (Fig. 2) . These deWcits might be related to downregulation of transcription of certain genes, including MGAT-3 and Toll-like receptors [15] .
In AD brain, macrophages are apoptotic through activation of caspases -6, -7, and -8 (Fig. 6e, f, g ), and they abut and inWltrate congophilic microvessels from the outside [11] (Fig. 6d) , in agreement with the assembly of Wbrils outside of the basal lamina [52] . Immunohistochemical studies of cerebral amyloid angiopathy (CAA) revealed its association with a signiWcant increase and activation of macrophages in leptomeningeal and cortical vesselsimplicating a central role for macrophages in amyloid angiopathy [53] . Furthermore, the BBB in AD brain is impaired [11] by immigrating macrophages (Fig. 1d) , thus allowing leakage of plasma proteins into the brain and further aggravation of angiopathy. Taken together, AD macrophages loaded with oligomeric A seem to suVer apoptosis, disintegrate and release oligomeric and Wbrillar A into the wall of congophilic vessels. Still, it is important to recognize that although phagocytosis of is generally greater in control monocytes compared to AD monocytes, this is a multifactorial and heterogeneous eVect, and monocytes of some aged control subjects occasionally demonstrate inferior innate immunity [15] and phagocytosis of A (SI Fig. 1) .
Proposed mechanisms for the pathogenesis of CAA have included production of A by myocytes in vessel walls [51] , derivation of A from blood or cerebrospinal Xuid, and, more recently, deposition of A from interstitial Xuid being drained from the central nervous system [49] . In APP-transgenic mice, amyloid angiopathy developed speciWcally in areas of the brain that over-produce A , suggesting that brain, as opposed to blood, is the major source of A [44] . In mice, tracers were injected intracerebrally and found to be distributed, similarly to A , within the basement membranes of intracerebral capillaries and arteries, and in leptomeningeal arteries [3] . Interestingly, within 24 h of injection the tracers Fig. 3 Fibrillar and protoWbrillar A (1-42) . Five microlitre of samples were spotted on a glowdischarged, carbon-coated Formvar grid and incubated for 5 min, washed with distilled water, Wxed with 2.5% glutaraldehyde, stained with a 1% (w/v) aqueous uranyl acetate solution, and examined using a JEOL transmission electron microscope were located in perivascular macrophages and these cells remained in brain microvessels, experiencing limited migration. Thus both drainage of the interstitial Xuid and shuttling of A by macrophages seem to lead to entrapment of A in perivascular macrophages.
The results of the experimental co-culture of normal subjects' monocytes with AD brain tissues show intrusion by these monocyte/macrophages into neurons and uploading of oligomeric A , suggesting a protective neuronal mechanism by the normal innate immune system. However, AD monocyte/macrophages seem to be defective in such protection of neurons [15] . Although we have not investigated this mechanism by electron microscopy of AD brain tissues, we have observed that macrophages and monocytes exposed to A in vitro develop proliWc microvilli and larger dendrites, which could reach into neurons and upload A [15] .
In animal models of amyloidosis, microglia were Wrst noted for their proinXammatory role [1] . Microglia of APOE4 transgenic mice produced more nitric oxide compared to APOE3 transgenic mice [5] . Subsequently, microglia were found to provide clearance of A and were assisted in clearing A deposits by antibodies [2] and by complement opsonization [16, 45, 46] . Clearance of A was recognized to include two phases: the Wrst mediated by antibodies and the second by microglia and antibodies [50] . However, in triple transgenic APP-thymidine kinase mice, bone marrow-derived rather than resident microglia restricted amyloid deposits as shown by ganciclovir destruction of microglia [36] .
However, human brain disorders involve both microglial activation and macrophage recruitment [40] . In AD brain, the initial inXammatory signal is induced by microglia [1] and neuronal chemokine RANTES. These stimuli attract large macrophages (clearly not resembling ramiWed microglia) to migrate across brain microvessels and invade neuritic plaques in AD brain [11] . Enzyme studies mitigate against the role of microglia in A clearance since, in comparison to macrophages, degradation of A by microglia is poor due to defective lysosomal enzymes [28] . The alternative emphasis on treating brain amyloidosis or inXammation has led to two diVerent therapeutic strategies in AD: A vaccination or anti-inXammatory drugs. In AD patients, a delicate balance between macrophage phagocytosis and microglial inXammation appears to be disturbed, leading to decreased phagocytosis and degradation, and increased inXammation. We propose that the innate immune clearance of A in AD brain involves shuttling of oligomeric A by AD macrophages from neurons to perivascular locations, apoptotic death of these macrophages, A spillage into the vessel wall, and seeding of congophilic angiopathy (Fig. 8) . We also speculate that brain amyloidosis may be cleared by stimulating AD macrophages using curcuminoids which increase phagocytosis [14, 15, 54] , and other approaches which enhance resistance to apoptosis and decrease inXammation. Fig. 8 Congophilic angiopathy immunopathogenesis. A is produced in neurons by cleavage of the amyloid-precursor protein (APP) by the -and -secretases, releasing A , which is re-uptaken into neurons and becomes oligomeric. Blood-borne monocytes (1) are attracted to neurons by chemokines produced by neurons (e.g. RANTES), intrude into neurons and neuritic plaques (2) , and upload oligomeric A from neurons and Wbrillar A in neuritic plaques. However, AD monocyte/macrophages (3) are heterogeneously deWcient in A clearance (uptake and degradation), and have deWcient MGAT-III transcription and increased activation of caspases leading to their apoptosis. Some AD macrophages loaded with A migrate to vessels (4) but are unable emigrate due to their engorgement with A and consequently undergo apoptosis. Simultaneously, soluble and oligomeric A have undergone peptide assembly into Wbrillar A , which is discharged into the vessel wall (5). Furthermore, congophilic angiopathy induces oxidative stress to neurons, and inXammatory cytokines produced by microglia potentiate neuronal damage 
